Probable Drug Shortages in US - Analyses of GMP deviations since 2018

 The report highlights those generic drugs that are at the risk of facing shortages due to CGMP issues faced by a prominent player in that drug segment. 

It also offers product opportunities for generic companies to target based on these potential shortages